Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Lupin Pharmaceuticals, Inc.
Current Parent Company: Lupin Limited
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $63,000,000
Year: 2019
Date: November 15, 2019
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Mega-Scandal: Drug Pricing Abuses
Violation Description: Lupin Pharmaceuticals agreed to pay $63 million to resolve litigation brought under the Texas Medicaid Fraud Prevention Act for reporting inflated drug prices to the Medicaid program.
Level of Government: state
Action Type: agency action
Agency: Texas Attorney General
Civil or Criminal Case: civil
Facility State: Texas
HQ Country of Current Parent: India
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.